Ra Medical’s Electrophysiology Division Announces First Use of New Product
Catheter Precision’s LockeT Successfully Used in Series of Patients
[…]
Catheter Precision’s LockeT Successfully Used in Series of Patients
[…]
EDISON, N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC PINK: ZRFY), the 21-year-old cybersecurity company focused on securing digital communications announced today that Mountain Entities Inc., has licensed Zerify Meet™ & Zerify Defender™ […]
VANCOUVER, BC, Feb. 21, 2023 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to report new assays on its Blueberry Zone including two high-grade intercepts in drillholes SR22-209, […]
EDISON, N.J., Feb. 21, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC Pink Sheets: ZRFY), the 21-year-old cybersecurity company focused on securing digital communications announced today that Yanis Development Group LLC., has chosen Zerify Meet as […]
Toronto, Ontario–(Newsfile Corp. – February 21, 2023) – Eric Sprott announces that on February 19, 2023, 8,888,889 common share purchase warrants (Warrants) of Scottie Resources Corp., (held by 2176423 Ontario Ltd., a corporation he beneficially […]
Apex Cybersecurity Has Contract With One of the Nation’s Largest Healthcare Providers […]
ANN ARBOR, MI / ACCESSWIRE / February 9, 2023 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported its preliminary unaudited […]
CALGARY, Alberta, Feb. 07, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat […]
The AcQBlate Force Sensing Ablation Catheter and System demonstrated 94% acute success with no serious adverse events and significantly less ablation time […]
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com